Recurrent optic nerve head infarctions associated with combined factor V Leiden- and factor II:G20210A-mutation

被引:7
作者
Cursiefen, C
Schönherr, U
Schwender, S
Grossmann, R
机构
[1] Univ Erlangen Nurnberg, Dept Ophthalmol, Hosp Eye, D-91054 Erlangen, Germany
[2] Univ Wurzburg, Med Univ Hosp, Cent Lab, Wurzburg, Germany
来源
ACTA OPHTHALMOLOGICA SCANDINAVICA | 1999年 / 77卷 / 06期
关键词
optic nerve head infarction; anterior ischaemic optic neuropathy (AION); factor V; factor II; mutation; thrombophilia;
D O I
10.1034/j.1600-0420.1999.770603.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To demonstrate the association of bilateral recurrent optic nerve head infarctions with thrombophilia due to combined factor V:R506Q- and factor II:G20210A-mutation. Methods: Case report. We examined a 55-year-old man with a two-year history of three segmental optic nerve head infarctions. Visual acuity was 20/80 on the left and 20/25 on the right eye. Results: Ophthalmologic, cardiologic, radiologic, neurologic and hematologic-immunologic examinations were unremarkable except for increased APC-resistance (APC ratio: 1.4; normal value >2) due to heterozygous factor V:R506Q-mutation and high factor II-leveIs due to factor If:G20210A-mutation, Therapy with coumarin was instituted at INR 2.0-3.0 and no relapse has occurred over the past 1-year period. Conclusion: Combined occurrence of thrombogenic factor II:G20210A-mutation and factor V:R506Q-mutation may be causally linked to recurrent optic nerve head infarctions.
引用
收藏
页码:625 / 627
页数:3
相关论文
共 8 条
[1]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[2]   FAMILIAL THROMBOPHILIA DUE TO A PREVIOUSLY UNRECOGNIZED MECHANISM CHARACTERIZED BY POOR ANTICOAGULANT RESPONSE TO ACTIVATED PROTEIN-C - PREDICTION OF A COFACTOR TO ACTIVATED PROTEIN-C [J].
DAHLBACK, B ;
CARLSSON, M ;
SVENSSON, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (03) :1004-1008
[3]  
Dahlback B, 1997, SEMIN HEMATOL, V34, P217
[4]   INHERITED RESISTANCE TO ACTIVATED PROTEIN-C IS CORRECTED BY ANTICOAGULANT COFACTOR ACTIVITY FOUND TO BE A PROPERTY OF FACTOR-V [J].
DAHLBACK, B ;
HILDEBRAND, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (04) :1396-1400
[5]   Is hormone replacement a risk factor for ischemic stroke in women with factor V Leiden mutation? [J].
Meschia, JF ;
Biller, J ;
Witt, T ;
Greist, A ;
Rhinehart, SN .
ARCHIVES OF NEUROLOGY, 1998, 55 (08) :1137-1139
[6]   Arterial vascular occlusion associated with factor V Leiden gene mutation [J].
Tayyanipour, R ;
Pulido, JS ;
Postel, EA ;
Lipkowitz, JL ;
Pisciotta, A ;
Braza, E .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1998, 18 (04) :376-377
[7]  
Worrall BB, 1997, J NEURO-OPHTHALMOL, V17, P162
[8]   The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families [J].
Zöller, B ;
Svensson, PJ ;
Dahlbäck, B ;
Hillarp, A .
BLOOD, 1998, 91 (06) :2210-2211